ANAB earnings
AnaptysBio (ANAB) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
ANAB earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Sep 21, 2026 | 5.11 | 5.11 | 0.00% | $27.49M |
| Q1 2026 | May 12, 2026 | -1.84 | -0.32 | -475.00% | $25.56M |
| Q4 2025 | Mar 3, 2026 | 1.58 | 0.89 | 77.53% | $108.25M |
| Q3 2025 | Nov 4, 2025 | 0.52 | -1.06 | 149.06% | $76.32M |
| Q2 2025 | Aug 7, 2025 | -1.34 | -1.50 | 10.67% | $22.26M |
| Q1 2025 | May 5, 2025 | -1.28 | -1.30 | 1.54% | $27.77M |
| Q4 2024 | Feb 27, 2025 | -0.72 | -1.55 | 53.55% | $43.11M |
| Q3 2024 | Nov 4, 2024 | -1.14 | -1.65 | 30.91% | $30.02M |
| Q2 2024 | Aug 5, 2024 | -1.71 | -0.99 | -72.73% | $10.97M |
| Q1 2024 | May 9, 2024 | -1.64 | -1.57 | -4.46% | $7.18M |
| Q4 2023 | Mar 12, 2024 | -1.59 | -1.60 | 0.63% | $9.01M |
| Q3 2023 | Nov 2, 2023 | -1.41 | -1.79 | 21.23% | $3.32M |
| Aug 6, 2023 | -1.50 | -1.70 | 11.76% | – | |
| May 11, 2023 | -1.58 | -1.05 | -50.48% | – | |
| Mar 1, 2023 | -0.93 | -0.96 | 3.12% | – | |
| Nov 8, 2022 | -1.18 | -0.72 | -63.89% | – | |
| Aug 8, 2022 | -1.15 | -1.02 | -12.75% | – | |
| May 4, 2022 | -1.31 | -0.99 | -32.32% | – | |
| Mar 7, 2022 | -1.13 | 2.57 | -143.97% | – | |
| Nov 4, 2021 | -0.24 | -0.74 | 67.57% | – |
- ANAB reports next on Nov 3, 2026, with EPS of 0.61 expected.
- ANAB beat EPS estimates in 25 of its last 39 reports.
Updated 2026-11-02 19:12 UTC